Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation

Vaccine. 1990 Feb;8(1):49-56. doi: 10.1016/0264-410x(90)90177-n.

Abstract

Mice and guinea pigs were immunized with the haemagglutinin (HA) of influenza B-USSR/100 virus, either in Syntex Adjuvant Formulation-1 (SAF-1) or in saline. Antibody titres were determined by ELISA, haemagglutination inhibition and virus neutralization. Animals immunized with HA in SAF-1 had significantly higher antibody titres than did animals immunized with HA in saline. Both 3-week-old and 13 1/2-month-old mice had greater and more uniform antibody responses to HA in SAF-1 than to HA in saline.

MeSH terms

  • Adjuvants, Immunologic*
  • Aging / immunology
  • Animals
  • Antibodies, Viral / biosynthesis*
  • Dose-Response Relationship, Immunologic
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Guinea Pigs
  • Hemagglutination Inhibition Tests
  • Hemagglutinins, Viral / immunology*
  • Immunization, Secondary
  • Immunoglobulin A / biosynthesis
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin M / biosynthesis
  • Influenza B virus / immunology*
  • Influenza Vaccines / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Neutralization Tests
  • Skin Tests

Substances

  • Adjuvants, Immunologic
  • Antibodies, Viral
  • Hemagglutinins, Viral
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Influenza Vaccines